MOTS-c (Mitochondrial Peptide)

MOTS-c and Exercise: What the Published Research Shows

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-233 cited sources

Reynolds and colleagues reported in Nature Communications in January 2021 that exercise induces MOTS-c expression, with skeletal-muscle levels rising approximately 12-fold and circulating levels approximately 1.6-fold in humans. The paper characterised MOTS-c as a regulator of age-dependent physical decline, with interventional work performed in mice.

Key facts

Publication
Nature Communications, 20 January 2021
PMID
33473109
Authors
Reynolds JC, Lai RW, Woodhead JST et al.
Skeletal muscle increase
~12-fold after exercise (human)
Circulating increase
~1.6-fold after exercise (human)
Interventional model
Mice
Human component
Observational — measured concentrations

What was actually measured in humans

The human portion of this work is observational. Researchers measured MOTS-c in skeletal muscle and in circulation before and after exercise, and found expression rose sharply in muscle — roughly 12-fold — with a much more modest rise of about 1.6-fold in the bloodstream. The discrepancy between those two figures is itself informative: it indicates a predominantly local, tissue-level response rather than a systemic endocrine surge.

What was done in mice

The interventional component — administering the peptide and observing outcomes — was performed in mouse models, where the paper reported effects on physical capacity and on markers associated with age-dependent decline. This is the standard structure for work of this kind, and the distinction between the observational human arm and the interventional animal arm is the single most important thing to keep straight when reading it.

Research material referenced

MOTS-C 10mg — third-party HPLC tested

View — £24.99

Why exercise induction is mechanistically coherent

Exercise imposes exactly the kind of metabolic stress that AMPK exists to sense, and MOTS-c sits upstream of AMPK. A mitochondrially encoded peptide that rises when mitochondrial demand rises, and that activates the cell's energy sensor, fits the biology rather than sitting oddly against it. The finding is consistent with the mechanism established in 2015 rather than independent of it.

What this does not establish

That a molecule increases naturally during exercise says nothing about what administering it would do. Many things rise with exercise — lactate, cortisol, interleukin-6 — and administering them does not reproduce exercise. The inference from 'exercise raises X' to 'X produces the benefits of exercise' is not supported by this paper and the paper does not make it.

Status in sport

MOTS-c is on the World Anti-Doping Agency prohibited list. Any research context involving competitive athletes needs to account for that, and it is a relevant fact about the compound regardless of the research question.

Extended research context

The MOTS-c (Mitochondrial Peptide) deep dive

Deep dive: why a peptide encoded in mitochondrial DNA is unusual

The human mitochondrial genome is 16,569 base pairs encoding 37 genes, and was considered fully characterised by the 1980s: thirteen respiratory-chain proteins, twenty-two transfer RNAs, two ribosomal RNAs. MOTS-c is encoded by a short open reading frame nested inside the 12S rRNA gene — sequence already annotated as doing something else, which is exactly why it went unnoticed. Humanin, found in 2001 inside the 16S rRNA gene, established that the genome held more than its annotation suggested; MOTS-c was found in 2015 by looking deliberately. The implication is that the mitochondrion encodes and releases signalling molecules of its own, rather than only executing instructions sent from the nucleus.

Deep dive: AMPK activation without touching AMPK

AMPK is normally activated when AMP and ADP bind its gamma subunit, making it a direct sensor of the AMP-to-ATP ratio. MOTS-c does not raise that ratio and does not bind the kinase. It inhibits the folate cycle, the one-carbon pathway feeding de novo purine biosynthesis, and the intermediate AICAR accumulates as a result. AICAR is an AMP mimetic — phosphorylated to ZMP, it binds the same regulatory site AMP occupies. So the peptide reaches a cytosolic energy sensor through one-carbon metabolism and a diffusible small molecule, which is a materially different architecture from a receptor-ligand interaction, and different again from metformin's inhibition of complex I.

Deep dive: reading a preclinical literature honestly

Roughly 250 indexed papers exist, and the overwhelming majority are cell and rodent studies. Where humans appear, the work is generally observational: measuring circulating concentrations and correlating them with age, fitness or metabolic state. The 2021 Nature Communications paper is the clearest example of the structure — the human arm measured MOTS-c before and after exercise, finding roughly a 12-fold rise in skeletal muscle against 1.6-fold in circulation, while the interventional work was done in mice. Two inferences the secondary literature routinely makes and the primary literature does not support: that a correlation between low concentrations and poor metabolic health establishes direction, and that a molecule which rises during exercise would reproduce exercise if administered.

Research applications

  • Study of mitochondrial-derived peptides and retrograde signalling
  • AMPK pathway research through non-canonical activation
  • One-carbon and folate-cycle metabolism models
  • Exercise physiology and mitochondrial bioenergetics research
  • Ageing biology and mitochondrial genome expression studies

Handling checklist

  • Store lyophilised material cold, dry and protected from light
  • Expect methionine oxidation as the primary degradation route (+16 Da per residue)
  • No reducing agent needed — the sequence contains no cysteine
  • Introduce diluent gently against the vial wall; swirl rather than shake
  • Aliquot to avoid repeated freeze-thaw cycles
  • Check mass spectrometry for +16 and +32 satellites before relying on a batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

Reading exercise induction as proof that administration mimics exercise

Fix: The papers report that exercise raises MOTS-c. The reverse inference is not supported and is not claimed.

Treating human observational data as interventional evidence

Fix: Human work measures endogenous concentrations; administration studies were conducted in mice.

Assuming MOTS-c has a cell-surface receptor like humanin

Fix: No receptor is established. Its characterised activity is intracellular.

Storing reconstituted material as though it were as stable as the powder

Fix: Solution-phase material is subject to hydrolysis and oxidation; the lyophilised form is far more stable.

Overlooking WADA status in athlete-adjacent research

Fix: MOTS-c is on the prohibited list; this is relevant to any research context involving competitors.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

  • What is MOTS-c?
  • What does MOTS-c stand for?
  • How does MOTS-c activate AMPK?
  • What is a mitochondrial-derived peptide?
  • How is MOTS-c different from humanin?
  • Does exercise increase MOTS-c?

Frequently asked questions

Does MOTS-c reproduce the effects of exercise?
Nothing in the published work establishes that. The paper reports that exercise induces MOTS-c; that is a different claim from the reverse.
Why did muscle levels rise so much more than blood levels?
The roughly 12-fold tissue rise against a 1.6-fold circulating rise indicates a predominantly local response rather than a systemic hormonal one.
Was the human work interventional?
No. The human component measured concentrations before and after exercise. Administration studies in that paper were conducted in mice.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

JM

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

More MOTS-c (Mitochondrial Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.